切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2024, Vol. 17 ›› Issue (03) : 493 -496. doi: 10.3877/cma.j.issn.1674-6902.2024.03.034

综述

肺小结节消融的现状与争议
姜华1, 金发光1,()   
  1. 1. 710038 西安,空军军医大学第二附属医院呼吸与危重症医学科
  • 收稿日期:2024-01-13 出版日期:2024-06-25
  • 通信作者: 金发光
  • 基金资助:
    国家公益性行业科研专项(201402024)

Current situation and controversy of pulmonary nodules ablation

Hua Jiang, Faguang Jin()   

  • Received:2024-01-13 Published:2024-06-25
  • Corresponding author: Faguang Jin
引用本文:

姜华, 金发光. 肺小结节消融的现状与争议[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 493-496.

Hua Jiang, Faguang Jin. Current situation and controversy of pulmonary nodules ablation[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(03): 493-496.

肺癌(carcinoma of the lungs)是最常见的癌症类型,非小细胞肺癌(non-small-cell lung cancer, NSCLC)占所有肺癌类型的85%[1,2]。手术是可切除NSCLC的首选治疗方案,但部分患者由于存在多种合并症或肺功能差,无法进行手术[3]。影像学引导下的局部治疗在这部分肺癌患者的治疗中起着重要的作用。影像学引导下的局部经皮消融治疗,如射频消融(radiofrequency ablation, RFA)、微波消融(microwave ablation, MWA)和冷冻消融(cryoablation, CA),越来越多地用于早期癌症的治疗[4,5,6]。随着影像技术的发展,越来越多的肺小结节被发现,本文旨在探讨消融在肺小结节应用的争议问题和未来研究方向。

1
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality world wide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
2
吴国明,钱桂生. 非小细胞肺癌靶向治疗研究进展及新理念[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(4): 405-408.
3
Ettinger DS, Wood DE, Aisner DL, et al. Non-small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2022, 20(5): 497-530.
4
Ghosn M, Solomon SB. Current management of oligometastatic lung cancer and future perspectives: results of thermal ablation as a local ablative therapy[J]. Cancers (Basel), 2021, 13(20): 5202.
5
Páez-Carpio A, Gómez FM, Isus Olivé G, et al. Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art[J]. Insights Imaging, 2021, 12(1): 57.
6
Mansur A, Garg T, Shrigiriwar A, et al. Image-guided percutaneous ablation for primary and metastatic tumors[J]. Diagnostics (Basel), 2022, 12(6): 1300.
7
Sonntag PD, Hinshaw JL, Lubner MG, et al. Thermal ablation of lung tumors[J]. Surg Oncol Clin N Am, 2010, 20(2): 369-387.
8
Palussière J, Catena V, Buy X. Percutaneous thermal ablation of lung tumors-Radiofrequency, microwave and cryotherapy: Where are we going?[J]. Diagn Interv Imaging, 2017, 98(9): 619-625.
9
Gala K, Shetty N, Patel P, et al. Microwave ablation: How we do it?[J]. Indian J Radiol Imaging, 2020, 30(2): 206-213.
10
Lin M, Eiken P, Blackmon S. Image guided thermal ablation in lung cancer treatment[J]. J Thorac Dis, 2020, 12(11): 7039-7047.
11
Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)[J]. Lancet Oncol, 2008, 9(7): 621-628.
12
Ni Y, Huang GH, Yang X, et al. Microwave ablation treatment for medically inoperable stage I non-small cell lung cancers: long-term results[J]. Eur Radiol, 2022, 32(8): 5616-5622.
13
Palussière J, Chomy F, Savina M, et al. Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase Ⅱ trial [J]. J Cardiothorac Surg, 2018, 13(1): 91.
14
Huang BY, Li XM, Song XY, et al. Long-term results of CT-guided percutaneous radiofrequency ablation of inoperable patients with stage Ia non-small cell lung cancer: A retrospective cohort study[J]. Int J Surg, 2018, 53(undefined): 143-150.
15
Iezzi R, Cioni R, Basile D, et al. Standardizing percutaneous Microwave Ablation in the treatment of Lung Tumors: a prospective multicenter trial (MALT study)[J]. Eur Radiol, 2021, 31(4): 2173-2182.
16
Michael L, Amita S, Digumarthy SR, et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer[J]. J Thorac Cardiovasc Surg, 2009, 137(1): 160-166.
17
Zhao H, Steinke K. Long-term outcome following microwave ablation of early- stage non-small cell lung cancer [J]. J Med Imaging Radiat Oncol, 2020, 64(6): 787-793.
18
Dupuy DE, Fernando HC, Hillman S, et al. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: results from the american college of surgeons oncology group Z4033 (Alliance) trial[J]. Cancer, 2015, 121(19): 3491-3498.
19
Nance M, Khazi Z, Kaifi J, et al. Computerized tomography-guided microwave ablation of patients with stage I non-small cell lung cancers: A single- institution retrospective study[J]. J Clin Imaging Sci, 2021, 11: 7.
20
Ambrogi MC, Fanucchi O, Cioni R, et al. Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study[J]. J Thorac Oncol, 2011, 6(12): 2044-2051.
21
Wang Y, Liu B, Cao P, et al. Comparison between computed tomography-guided percutaneous microwave ablation and thoracoscopic lobectomy for stage I non-small cell lung cancer[J]. Thorac Cancer, 2018, 9(11): 1376-1382.
22
Xia Y, Xin YE, Zheng A, et al. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases [J]. J Surg Oncol, 2014, 110(6): 758-763.
23
Narsule CK, Sridhar P, Nair D, et al. Percutaneous thermal ablation for stage IA non-small cell lung cancer: long-term follow-up[J]. J Thorac Dis, 2017, 9(10): 4039-4045.
24
Ito N, Nakatsuka S, Inoue M, et al. Computed tomographic appearance of lung tumors treated with percutaneous cryoablation[J]. J Vase Interv Radiol, 2012, 23(8): 1043-1052.
25
Nomori H, Yamazaki I, Shiraishi A, et al. Cryoablation for T1N0M0 non-small cell lung cancer using liquid nitrogen[J]. Eur J Radiol, 2020, 133: 109334.
26
Liu SP, Zhu XH, Qin ZL, et al. Computed tomography-guided percutaneous cryoablation for lung ground-glass opacity: A pilot study[J]. J Cancer Res Ther, 2019, 15(2): 370-374.
27
Ye X, Fan W, Wang Z, et al. Expert consensus on thermal ablation therapy of pulmonary subsolid nodules (2021 Edition) [J]. J Cancer Res Ther, 2021, 17(5): 1141-1156.
28
Mikami S, Tateishi R, Akahane M, et al. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience[J]. J Vasc Interv Radiol, 2012, 23(10): 1269-1275.
29
Minami Y, Kudo M. Imaging modalities for assessment of treatment response to nonsurgical hepatocellular carcinoma therapy: Contrast-Enhanced US, CT, and MRI[J]. Liver Cancer, 2015, 4(2): 106-114.
30
Roman A, Kaltenbach B, Gruber-Rouh T, et al. The role of MRI in the early evaluation of lung microwave ablation[J]. Int J Hyperthermia, 2018, 34(6): 883-890.
31
Beland MD, Wasser EJ, Mayo-Smith WW, et al. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation[J]. Radiology, 2010, 254(1): 301-307.
32
Bi N, Shedden K, Zheng X, et al. Comparison of the effectiveness of radiofrequency ablation with stereotactic body radiation therapy in inoperable stage I non-small cell lung cancer: a systemic review and pooled analysis[J]. Int J Radiat Oncol Biol Phys, 2016, 95(5): 1378-1390.
33
Zhang R, Kang J, Ren S, et al. Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis[J]. Ann Transl Med, 2022, 10(2): 104.
34
Uhlig J, Ludwig JM, Goldberg SB, et al. Survival rates after thermal ablation versus stereotactic radiation therapy for stage I non-small cell lung cancer: a national cancer database study[J]. Radiology, 2018, 289(3): 862-870.
35
Mendogni P, Daffre E, Rosso L, et al. Percutaneous lung microwave ablation versus lung resection in high-risk patients. A monocentric experience[J]. Acta Biomed, 2020, 91(10S): e2020002.
36
Wu J, Bai HX, Chan L, et al. Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: a national cancer database study[J]. J Thorac Cardiovasc Surg, 2020, 160(5): 1350-1357.
37
Zeng C, Lu J, Tian Y, et al. Thermal ablation versus wedge resection for stage I non-small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database[J]. Front Oncol, 2020, 10: 571684.
38
Zhao H, Fan K, Wang HY, et al. Treatment of stage Ia non-small cell lung cancer in patients: comparison of ablation and sub-lobectomy[J]. Zhongguo Fei Ai Za Zhi, 2021, 24(9): 613-622.
39
Callstrom MR, Woodrum DA, Nichols FC, et al. Multicenter study of metastatic lung tumors targeted by interventional cryoablation evaluation (SOLSTICE)[J]. J Thorac Oncol, 2020, 15(7): 1200-1209.
40
Wang Q, Huang J, Ma K, et al. Evaluation of ghost cell survival in the area of radiofrequency ablation[J]. PLoS One, 2012, 7(12): e53158.
41
Tselikas L, de Baere T, Deschamps F, et al. Diagnostic yield of a biopsy performed immediately after lung radiofrequency ablation[J]. Eur Radiol, 2017, 27(3): 1211-1217.
42
Wang J, Ni Y, Yang X, et al. Diagnostic ability of percutaneous core biopsy immediately after microwave ablation for lung ground-glass opacity[J]. J Cancer Res Ther, 2019, 15(4): 755-759.
43
Alzubaidi SJ, Liou H, Saini G, et al. Percutaneous image-guided ablation of lung tumors[J]. J Clin Med, 2021, 10(24): 5783.
44
Aufranc V, Farouil G, Abdel-Rehim M, et al. Percutaneous thermal ablation of primary and secondary lung tumors: Comparison between microwave and radiofrequency ablation[J]. Diagn Interv Imaging, 2019, 100(12): 781-791.
45
Tafti BA, Genshaft S, Suh R, et al. Lung ablation: indications and techniques[J]. Semin Intervent Radiol, 2019, 36(3): 163-175.
46
Abtin F, De Baere T, Dupuy DE, et al. Updates on current role and practice of lung ablation[J]. J Thorac Imaging, 2019, 34(4): 266-277.
47
Vyas V, Paul M. Catastrophic complications following cryoablation of lung cancer[J]. Proc (Bayl Univ Med Cent), 2020, 34(1): 131-132.
48
Alexander ES, Dupuy DE. Lung cancer ablation: technologies and techniques[J]. Semin Intervent Radiol, 2013, 30(2): 141-150.
49
Palussière J, Cazayus M, Cousin S, et al. Is there a role for percutaneous ablation for early stage lung cancer? What is the evidence?[J]. Curr Oncol Rep, 2021, 23(7): 81.
50
Venturini M, Cariati M, Marra P, et al. CIRSE standards of practice on thermal ablation of primary and secondary lung tumours[J]. Cardiovasc Intervent Radiol, 2020, 43(5): 667-683.
51
Genshaft SJ, Suh RD, Abtin F, et al. Society of interventional radiology multidisciplinary position statement on percutaneous ablation of non-small cell lung cancer and metastatic disease to the lungs: endorsed by the Canadian Association for Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, and the Society of Interventional Oncology[J]. J Vasc Interv Radiol, 2021, 32(8): 1241.e1-e12.
52
Wang M, Wei Z, Ye X. Issues and prospects of image-guided thermal ablation in the treatment of primary and metastatic lung tumors[J]. Thorac Cancer, 2023, 14(1): 110-115.
[1] 诸佳玮, 陈强, 王辉阳, 蒋天安. 双极射频活检针在肝粗针活检止血的研发与初步应用[J]. 中华医学超声杂志(电子版), 2024, 21(01): 69-74.
[2] 赵里汶, 贺需旗, 李凯. 虚拟导航辅助超声引导下经皮射频消融治疗直径≤2 cm肾上腺良性肿瘤的疗效研究[J]. 中华医学超声杂志(电子版), 2023, 20(12): 1282-1286.
[3] 李云龙, 夏旭良, 江志强, 刘伟, 刘凯, 唐立, 刘昊中, 张思远. 三种方法治疗分化型甲状腺癌的临床疗效[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 487-489.
[4] 林巧, 周丽. RFA联合LAH术治疗原发性肝癌并门静脉癌栓的临床效果分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 521-524.
[5] 吴文娟, 王小莉, 刘娟. 乳腺结节微创手术治疗进展研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 229-232.
[6] 李月平, 李科, 乔禹铭, 钟美浓. 前列腺热蒸汽消融术医护康一体化快速康复模式初探[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 464-472.
[7] 杨涛, 吕学祥, 李念, 王燕红, 余梦琳, Menglin Yu. 阵发性房颤射频消融术后肺静脉狭窄的临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(06): 814-817.
[8] 刘磊, 张琪, 范兴彪. 基于放射性特征预测肺结节侵袭性的临床应用[J]. 中华肺部疾病杂志(电子版), 2023, 16(06): 880-882.
[9] 宋华传, 季鹏, 姚焕章, 王永帅, 张珅瑜, 宋瑞鹏, 王继洲. 腹腔镜肝切除术联合微波消融治疗多发性结直肠癌肝转移[J]. 中华腔镜外科杂志(电子版), 2024, 17(04): 222-226.
[10] 沈佳佳, 何经雄, 王芳, 江艺, 潘凡, 张小进. ICG荧光引导腹腔镜射频消融在合并严重大结节肝硬化小肝癌患者治疗中的应用[J]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 68-71.
[11] 莫鹏, 郭杏春, 梁秀娟, 王耀明. 超声引导与CT引导射频消融治疗肝细胞癌患者疗效及预后比较[J]. 中华消化病与影像杂志(电子版), 2024, 14(02): 151-154.
[12] 张朋伟, 杨朝凤, 李杨. 结直肠癌肝转移介入治疗的研究进展[J]. 中华消化病与影像杂志(电子版), 2024, 14(02): 177-182.
[13] 蒲丹, 龙煊, 周玉龙, 李甘霖. 血清外泌体miR-224对结直肠癌肝转移患者射频消融治疗后复发的预测价值[J]. 中华消化病与影像杂志(电子版), 2024, 14(01): 45-52.
[14] 萨仁高娃, 张英霞, 邓伟, 闫诺, 樊宁. 超声引导下鼠肝消融术后组织病理特征的变化规律及影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 394-398.
[15] 罗汐, 田伟, 孙汉垚, 路尚于, 施海彬. 铁铜基纳米材料在肝癌微波增敏治疗中的应用效果[J]. 中华介入放射学电子杂志, 2024, 12(01): 51-57.
阅读次数
全文


摘要